PubRank

Walter Weder

Author PubWeight™ 141.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003 7.64
2 Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012 5.28
3 EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia 2008 5.22
4 Long-term outcomes of bilateral lobar lung transplantation. Eur J Cardiothorac Surg 2012 2.76
5 Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol 2012 2.57
6 ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007 2.37
7 ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006 2.33
8 Catamenial pneumothorax revisited: clinical approach and systematic review of the literature. J Thorac Cardiovasc Surg 2004 2.26
9 Thoracoscopic treatment of pulmonary sequestration. Eur J Cardiothorac Surg 2006 2.09
10 Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008 2.06
11 A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience. J Thorac Oncol 2015 1.99
12 Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014 1.90
13 Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncol 2009 1.81
14 CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Eur J Cardiothorac Surg 2011 1.76
15 The BODE index after lung volume reduction surgery correlates with survival. Chest 2006 1.66
16 Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy. Eur J Cardiothorac Surg 2012 1.65
17 Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004 1.57
18 Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells. Am J Respir Crit Care Med 2013 1.50
19 Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003 1.50
20 Tolerability, safety and efficacy of conventional amphotericin B administered by 24-hour infusion to lung transplant recipients. Swiss Med Wkly 2002 1.41
21 Lung transplantation for cystic fibrosis: a single center experience of 100 consecutive cases. Eur J Cardiothorac Surg 2011 1.40
22 Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer 2011 1.39
23 Sildenafil extends survival and graft function in a large animal lung transplantation model. Eur J Cardiothorac Surg 2006 1.39
24 Surfactant improves graft function after gastric acid-induced lung damage in lung transplantation. Ann Thorac Surg 2012 1.39
25 The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg 2013 1.31
26 Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2006 1.28
27 Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005 1.25
28 Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology 2009 1.22
29 Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer 2008 1.22
30 Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol 2014 1.20
31 A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009 1.18
32 Accelerated treatment of postpneumonectomy empyema: a binational long-term study. J Thorac Cardiovasc Surg 2008 1.15
33 The MARS feasibility trial: conclusions not supported by data. Lancet Oncol 2011 1.13
34 Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010 1.10
35 Diagnosis, treatment and long-term outcome of solitary fibrous tumours of the pleura. Eur J Cardiothorac Surg 2007 1.06
36 Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res 2012 1.05
37 Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg 2009 1.04
38 Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008 1.03
39 The postpneumonectomy syndrome: clinical presentation and treatment. Eur J Cardiothorac Surg 2008 1.03
40 Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2002 1.02
41 Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration 2003 0.99
42 Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng Des Sel 2006 0.98
43 L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer 2011 0.98
44 Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide. Peptides 2009 0.92
45 Impact of preoperative right-ventricular function and platelet transfusion on outcome after lung transplantation. Eur J Cardiothorac Surg 2010 0.91
46 PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. J Thorac Oncol 2014 0.90
47 Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee. J Thorac Oncol 2014 0.90
48 Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency. J Thorac Cardiovasc Surg 2004 0.89
49 Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer 2011 0.89
50 Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort study. BMC Pulm Med 2014 0.89
51 PTEN expression is a strong predictor of survival in mesothelioma patients. Eur J Cardiothorac Surg 2008 0.89
52 Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. J Thorac Oncol 2014 0.89
53 Immunosuppressive therapy in lung transplantation: state of the art. Eur J Cardiothorac Surg 2009 0.88
54 Prospective European multicenter randomized trial of PleuraSeal for control of air leaks after elective pulmonary resection. J Thorac Cardiovasc Surg 2010 0.88
55 Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics 2004 0.87
56 Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007 0.86
57 Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. Eur J Cancer 2010 0.86
58 Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment. Eur J Cardiothorac Surg 2007 0.86
59 Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008 0.86
60 Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer 2012 0.86
61 Tissue-engineered trachea: History, problems and the future. Eur J Cardiothorac Surg 2006 0.86
62 Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer 2008 0.86
63 Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis 2011 0.86
64 Melatonin attenuates posttransplant lung ischemia-reperfusion injury. Ann Thorac Surg 2002 0.86
65 Outcome of Extracorporeal Membrane Oxygenation as a Bridge To Lung Transplantation: An Institutional Experience and Literature Review. Transplantation 2015 0.86
66 Simplified rat lung transplantation by using a modified cuff technique. J Invest Surg 2008 0.85
67 D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol 2007 0.85
68 Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer. Lung Cancer 2004 0.84
69 True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant 2009 0.84
70 Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer 2012 0.84
71 The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered trachea. Tissue Eng Part A 2009 0.83
72 Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg 2005 0.83
73 Small animal models of experimental obliterative bronchiolitis. Am J Respir Cell Mol Biol 2013 0.83
74 Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation. Ann Thorac Surg 2006 0.83
75 Chest surgical disorders in ancient Egypt: evidence of advanced knowledge. Ann Surg 2012 0.82
76 CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats. J Heart Lung Transplant 2006 0.82
77 Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide. Transplantation 2009 0.82
78 N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg 2007 0.82
79 Primary sclerosing epithelioid fibrosarcoma of the lung in a patient with Lynch syndrome. Lung 2012 0.82
80 Melatonin in vivo prolongs cardiac allograft survival in rats. J Pineal Res 2004 0.82
81 Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008 0.82
82 Automated ERCC1 immunohistochemistry in non-small cell lung cancer: comparison of anti-ERCC1 antibodies 8F1, D-10, and FL-297. Appl Immunohistochem Mol Morphol 2011 0.81
83 Tissue engineered cartilage generated from human trachea using DegraPol scaffold. Eur J Cardiothorac Surg 2003 0.81
84 Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. Eur J Cardiothorac Surg 2009 0.81
85 Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation 2004 0.81
86 The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection. Transplantation 2009 0.80
87 Malignant pleural mesothelioma. Future Oncol 2009 0.80
88 Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea. Eur J Cardiothorac Surg 2007 0.80
89 Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. J Heart Lung Transplant 2010 0.80
90 Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study. J Thorac Cardiovasc Surg 2011 0.79
91 Patterns of changes in arterial PO2 during one-lung ventilation: a comparison between patients with severe pulmonary emphysema and patients with preserved lung function. J Cardiothorac Vasc Anesth 2005 0.79
92 Caveolin-1 Expression and Hemodynamics in COPD Patients. Open Respir Med J 2009 0.79
93 Anatomical 3D fiber-deposited scaffolds for tissue engineering: designing a neotrachea. Tissue Eng 2007 0.79
94 MR imaging by using very short echo-time sequences after syngeneic lung transplantation in mice. Radiology 2012 0.79
95 Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach? Curr Opin Oncol 2009 0.79
96 Effect of N-acetylcysteine on acute allograft rejection after rat lung transplantation. Ann Thorac Surg 2013 0.79
97 Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation. J Cyst Fibros 2011 0.79
98 Inflammation patterns in allogeneic and autologous airway tissue of lung transplant recipients. Am J Transplant 2005 0.79
99 Ischaemia-reperfusion injury in orthotopic mouse lung transplants - a scanning electron microscopy study. Int J Exp Pathol 2011 0.79
100 The depletion of donor macrophages reduces ischaemia-reperfusion injury after mouse lung transplantation. Eur J Cardiothorac Surg 2013 0.79
101 Thoracic sympathectomy. Curr Probl Dermatol 2002 0.79
102 Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma. J Biomol Tech 2010 0.78
103 The effect of low-dose Continuous Erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury. Eur J Pharmacol 2011 0.78
104 Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. J Heart Lung Transplant 2007 0.78
105 Ten years of lung transplantation in Switzerland: results of the Swiss Lung Transplant Registry. Swiss Med Wkly 2004 0.78
106 Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer 2008 0.78
107 Acute amiodarone-induced pulmonary toxicity after lung operation. Ann Thorac Surg 2002 0.78
108 Transphrenic budding of the liver. Ann Thorac Surg 2009 0.78
109 Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer. Eur J Cardiothorac Surg 2011 0.77
110 Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation. Pulm Pharmacol Ther 2010 0.77
111 Surfactant alterations following donation after cardiac death donor lungs. Transpl Int 2010 0.77
112 Intra-scaffold continuous medium flow combines chondrocyte seeding and culture systems for tissue engineered trachea construction. Interact Cardiovasc Thorac Surg 2008 0.77
113 Lung transplantation in Kartagener syndrome and situs inversus: potential of multidetector row computed tomography and three-dimensional postprocessing. J Thorac Cardiovasc Surg 2007 0.77
114 Silver-enhanced in situ hybridization for determination of EGFR copy number alterations in non-small cell lung cancer. Am J Surg Pathol 2012 0.77
115 Perspectives of novel imaging techniques for staging, therapy response assessment, and monitoring of surveillance in lung cancer: summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop. J Thorac Oncol 2015 0.77
116 Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion. J Pineal Res 2008 0.77
117 Size-reduced lung transplantation in children--an option worth to consider! Pediatr Transplant 2009 0.77
118 Zurich University Hospital lung transplantation programme: update 2012. Swiss Med Wkly 2013 0.77
119 KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics Proteomics 2012 0.76
120 The influence of the rapamycin-derivate SDZ RAD on the healing of airway anastomoses. Eur J Cardiothorac Surg 2003 0.76
121 Gain and subsequent loss of lung function after lung volume reduction surgery in cases of severe emphysema with different morphologic patterns. J Thorac Cardiovasc Surg 2002 0.76
122 Perioperative diclofenac application during video-assisted thoracic surgery pleurodesis modulates early inflammatory and fibrinolytic processes in an experimental model. Eur Surg Res 2013 0.76
123 Extended surgical resection in stage III non-small cell lung cancer. Front Radiat Ther Oncol 2009 0.76
124 Simultaneous bilateral lobar lung transplantation: one donor serves two recipients. Ann Thorac Surg 2013 0.76
125 Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer 2011 0.76
126 Iron accumulation in lung allografts is associated with acute rejection but not with adverse outcome. Chest 2005 0.76
127 Minimally invasive resection of thymomas with the da Vinci® Surgical System. Eur J Cardiothorac Surg 2012 0.76
128 Ultrastructural changes in acute lung allograft rejection: novel insights from an animal study. J Heart Lung Transplant 2012 0.76
129 Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation. J Surg Res 2013 0.75
130 Impact of topical cooling solution and prediction of pulmonary graft viability from non-heart-beating donors. J Heart Lung Transplant 2008 0.75
131 Distribution of macrophages and T cells in syngrafts and allografts after experimental rat lung transplantation. Immunobiology 2009 0.75
132 Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma. J Comput Assist Tomogr 2015 0.75
133 Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon? Swiss Med Wkly 2003 0.75
134 Reply to Eberlein et al. Eur J Cardiothorac Surg 2013 0.75
135 Airway complications after lung transplantation can be avoided without bronchial artery revascularization. Curr Opin Organ Transplant 2010 0.75
136 Influence of Sinogram-Affirmed Iterative Reconstruction on Computed Tomography-Based Lung Volumetry and Quantification of Pulmonary Emphysema. J Comput Assist Tomogr 2016 0.75
137 Mastering mouse lung transplantation from scratch--a track record. J Surg Res 2013 0.75
138 Acute respiratory distress syndrome in a lung transplant recipient infected by a pUL97-mutated cytomegalovirus associated with decreased phosphorylation of ganciclovir. Respiration 2002 0.75
139 Prevention of recurrent empyema after pneumonectomy for chronic infection. Eur J Cardiothorac Surg 2002 0.75
140 Chronic Airway Fibrosis in Orthotopic Mouse Lung Transplantation Models - An Experimental Reappraisal. Transplantation 2017 0.75
141 Successful lung volume reduction surgery in a child with severe airflow obstruction and hyperinflation due to constrictive bronchiolitis. Chest 2002 0.75
142 Model-based versus clinical prediction of the spirometric response to lung volume reduction surgery. Respiration 2005 0.75
143 A curious case of convulsion. Lancet 2010 0.75
144 The role of CD26/DPP IV in preservation of early pulmonary graft function. Adv Exp Med Biol 2006 0.75
145 Which Anesthesia Regimen Is Best to Reduce Morbidity and Mortality in Lung Surgery?: A Multicenter Randomized Controlled Trial. Anesthesiology 2016 0.75
146 Donor predicted post-operative forced expiratory volume in one second predicts recipients' best forced expiratory volume in one second following size-reduced lung transplantation. Eur J Cardiothorac Surg 2010 0.75
147 [Impact of surgical intervention in the treatment of pulmonary tuberculosis]. Ther Umsch 2011 0.75
148 News on lung volume reduction surgery. Swiss Med Wkly 2002 0.75
149 Neoadjuvant chemotherapy in malignant pleural mesothelioma. Lung Cancer 2005 0.75
150 Trachea reconstruction using novel tissue engineered constructs. Swiss Med Wkly 2007 0.75
151 Intra-operative extracorporeal membrane oxygenation use in pediatric lung transplantation--the Zurich experience. Pediatr Transplant 2013 0.75
152 Patient selection for lung volume reduction surgery: is outcome predictable? Semin Thorac Cardiovasc Surg 2002 0.75